1-19232655-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PM5PP3PP5
The ENST00000477853.6(EMC1):c.1751C>G(p.Pro584Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P584H) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000477853.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EMC1 | NM_015047.3 | c.1751C>G | p.Pro584Arg | missense_variant | 15/23 | ENST00000477853.6 | NP_055862.1 | |
EMC1-AS1 | NR_135114.1 | n.175-7602G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EMC1 | ENST00000477853.6 | c.1751C>G | p.Pro584Arg | missense_variant | 15/23 | 1 | NM_015047.3 | ENSP00000420608 | P4 | |
EMC1-AS1 | ENST00000437898.3 | n.213-7602G>C | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cerebellar atrophy, visual impairment, and psychomotor retardation; Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | May 11, 2023 | The c.1751C>G variant in EMC1 has not previously been reported in the literature and it has been deposited in ClinVar [ClinVar ID: 801455] as a Likely Pathogenic with cerebellar atrophy, visual impairment, and psychomotor retardation phenotype. The c.1751C>G variant is absent from population databases (gnomAD v2.1.1 and v3.1.2,TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases. The c.1751C>G variant is located in exon 15 of this 23-exon gene and is predicted to replace an evolutionary conserved proline amino acid with arginine at position 584 (p.(Pro584Arg)) in the beta-propeller domain of the protein [PMID: 35234901]. In silico predictions for p.(Pro584Arg) are inconclusive of the variant's effect [(CADD v1.6 = 28.4, REVEL = 0.438)]; however, there are no functional studies to support or refute these predictions. A different missense variant p.(Pro584His) affecting the same amino acid has been reported in the literature segregating as de novo heterozygous variant in a 5 years old boy with global developmental delay, no speech, seizure, truncal hypotonia, cortical visualimpairment, roving eye movement, cerebellar atrophy, and hip dysplasia [PMID:35234901] and in ClinVar [ClinVar ID: 521479] as a Likely Pathogenic in a male individual with severe global developmental delay, cortical visual impairment, and generalized hypotonia phenotypes. Based on available evidence this de novo c.1751C>G p.(Pro584Arg) variant identified in EMC1 is classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 17, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at